Archived 2 years ago from Epoch TimesFDA Approves First mRNA Vaccine for RSV in Older Adults
The U.S. Food and Drug Administration (FDA) has approved Moderna’s mRESVIA, an mRNA vaccine that will protect adults aged 60 and older from respiratory syncytial virus (RSV), a lower respiratory tract disease that kills 6,000 to 10,000 people aged 65 and above each year.This approval marks the …
Read More